We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Sport Biochemistry Analyzers Measure Blood Lactate Concentration

By Labmedica staff writers
Posted on 18 Feb 2008
Sport biochemistry analyzers for the measurement of blood lactate acid are used during training for many types of sports, from swimming to premiership football clubs. More...
The analyzers use an enzyme immobilizer technique.

Biologic measuring dimensions of oxygen absorption, heart frequency, and blood lactate concentration form the basis of sports medicine diagnostics. Because of the minimal sensitivity of heart frequency and the limited means of measuring oxygen absorption, the blood lactate parameter has proved to have an application in performance sport.

The exercise intensity at which the aerobic mechanism can no longer cover the needs of the working muscles is generally detectable as an increase in blood lactate concentration and a disproportionate increase in the ventilation rate. This is described as the anaerobic threshold.

The YSI 2300 and 1500 Sport, products of YSI Life Sciences (Yellow Springs, OH, USA), give the required clinical accuracy and precision, as well as affordability, needed to interpret blood results into training regimes.

The YSI 2300 measures lactate in whole blood, plasma, or cerebrospinal fluid providing results in one minute or less. The immobilized enzymes do not have to be renewed after each test, minimizing the use of costly reagents and supplies. The analyzer needs a small sample size (25 µl) and is simple and safe to operate. Menu-driven software guides operators through each step. Diagnostics provide performance analysis and troubleshooting. Samples are introduced to the analyzer by tubes or syringe; no needles are required. Samples can be run in batches and each batch is assigned each identification number with date and time.

Calibration is automatic, so the analyzer is always ready. YSI immobilized enzyme technology eliminates most of the interferences that plague other methods. The broad measurement range of up to 30 mmol/l lactate virtually eliminates the need for sample dilution.

The YSI 1500 Sport lactate analyzer also uses a sample of 25µl blood and results are available in 30 seconds. It has a manual calibration mode that is displayed in 30 seconds. Sample to sample interval is 60 seconds. The automatic calibration mode is displayed in 60 seconds.


Related Links:
YSI Life Sciences

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.